Abstract:Background: Group 2 innate lymphoid cells (ILC2s) are critical mediators of type 2 respiratory inflammation, releasing IL-5 and IL-13 and promoting the pulmonary eosinophilia associated with allergen provocation. Although ILC2s have been shown to promote eosinophil activities, the role of eosinophils in group 2 innate lymphoid cell (ILC2) responses is less well defined. Objective: We sought to investigate the role of eosinophils in activation of ILC2s in models of allergic asthma and in vitro. Methods: Inducible eosinophil-deficient mice were exposed to allergic respiratory inflammation models of asthma, such as ovalbumin or house dust mite challenge, or to innate models of type 2 airway inflammation, such as inhalation of IL-33. Eosinophil-specific IL-4/13-deficient mice were used to address the specific roles for eosinophil-derived cytokines. Direct cell interactions between ILC2s and eosinophils were assessed by in vitro culture experiments. Results: Targeted depletion of eosinophils resulted in significant reductions of total and IL-5+ and IL-13+ lung ILC2s in all models of respiratory inflammation. This correlated with reductions in IL-13 levels and mucus in the airway. Eosinophil-derived IL-4/13 was necessary for both eosinophil and ILC2 accumulation in lung in allergen models. In vitro, eosinophils released soluble mediators that induced ILC2 proliferation and G protein-coupled receptor-dependent chemotaxis of ILC2s. Coculture of ILC2s and IL-33-activated eosinophils resulted in transcriptome changes in both ILC2s and eosinophils, suggesting potential novel reciprocal interactions. Conclusion: These studies demonstrate that eosinophils play a reciprocal role in ILC2 effector functions as part of both adaptive and innate type 2 pulmonary inflammatory events.

The E3 Ligase VHL Controls Lung Inflammation by Regulating Epithelium-ILC2 Cross-talk

Hypoxia induces adrenomedullin from lung epithelia, stimulating ILC2 inflammation and immunity

E3 Ligase VHL Promotes Group 2 Innate Lymphoid Cell Maturation and Function Via Glycolysis Inhibition and Induction of Interleukin-33 Receptor.

The E3 Ligase VHL Controls Alveolar Macrophage Function Via Metabolic-Epigenetic Regulation

Lung Dysfunction in a Mouse Model of Inflammation is Dependent on T-cell-independent IL-13 Expression (54.18)

The Origin and Role of Innate Lymphoid Cells in the Lung

E3 Ubiquitin Ligase Vhl Regulates Hypoxia-Inducible Factor-1 Alpha To Maintain Regulatory T Cell Stability And Suppressive Capacity

Sensing and signaling of immunogenic extracellular RNAs restrain group 2 innate lymphoid cell-driven acute lung inflammation and airway hyperresponsiveness

Interleukin-4 and interferon-γ orchestrate an epithelial polarization in the airways

Eosinophils promote effector functions of lung group 2 innate lymphoid cells in allergic airway inflammation in mice

House dust mite allergen directly activates ILC2 cells via the TLR4 signaling pathway in allergic airway diseases

ICAM-1 Controls Development and Function of ILC2

An ILC2-chitinase circuit restores lung homeostasis after epithelial injury

Airway Epithelial TSLP Production of TLR2 Drives Type 2 Immunity in Allergic Airway Inflammation

E3 Ubiquitin Ligase Cbl-b Inhibits Type 2 Innate Lymphoid Cell Development by Targeting ST2 for Ubiquitination

The E3 Ligase VHL Promotes Follicular Helper T Cell Differentiation Via Glycolytic-Epigenetic Control.

Lipid droplet messengers

Modulating ILC2 function for treatment of type 2 airway diseases

Esophageal ILC2s mediate abnormal epithelial remodeling in eosinophilic esophagitis via Areg-EGFR signaling

HMGB1-induced ILC2s Activate Dendritic Cells by Producing IL-9 in Asthmatic Mouse Model.

The role of hormones in ILC2‐driven allergic airway inflammation